A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
10/2006
10/19/2006	CA2602303A1 Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents
10/19/2006	CA2600709A1 Use of cd25 antibodies in immunotherapy
10/19/2006	CA2598578A1 Antitumor combination comprising substituted acryloyl distamycin derivatives and antibodies inhibiting growth factors or their receptors
10/19/2006	CA2584075A1 Combined treatment with radiation and an epidermal growth factor receptor kinase inhibitor
10/19/2006	CA2583520A1 Combined treatment with bortezomib and an epidermal growth factor receptor kinase inhibitor
10/18/2006	EP1712642A1 Method of examining sensitivity of cancer cell to anticancer agent
10/18/2006	EP1712619A1 Preventive/remedy for cancer
10/18/2006	EP1712565A1 Cell death inducing agents
10/18/2006	EP1712563A1 Method of isolating monocytes
10/18/2006	EP1712243A1 Gene therapy for tumor using minus-strand rna viral vectors encoding immunostimulatory cytokines
10/18/2006	EP1712241A1 Composition for treating cancer adapted for intra-tumoral administration and uses thereof
10/18/2006	EP1712239A2 Interleukin-1 inhibitors in the treatment of diseases
10/18/2006	EP1712238A1 Anthracyclin induced immunogenic dead or dying cells composition
10/18/2006	EP1712235A2 Combinational therapy involving a small molecule inhibitor of the MDM2: P53 interaction
10/18/2006	EP1712234A1 Use of 4-Pyridylmethylphthalazines for Cancer Treatment
10/18/2006	EP1711618A1 Methods for detecting markers associated with endometrial disease or phase
10/18/2006	EP1711528A2 Treatment of cancer with novel anti-il 13 monoclonal antibodies
10/18/2006	EP1711527A2 Hla-dr-specific antibodies, compositions and methods
10/18/2006	EP1711499A2 Fused pyrrolocarbazoles and methods for the preparation thereof
10/18/2006	EP1711496A1 Thiazole compounds
10/18/2006	EP1711487A1 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
10/18/2006	EP1711462A1 Proline derivatives used as pharmaceutical active ingredients for the treatment of tumours
10/18/2006	EP1711461A2 N-deacetylthiocolchicine derivatives, their use and pharmaceutical formulations containing them
10/18/2006	EP1711210A2 Combined use of prame inhibitors and hdac inhibitors
10/18/2006	EP1711209A1 Methods of treating mesothelioma using an antisense oligonucleotide to thymidylate synthase
10/18/2006	EP1711188A2 Anti-cancer therapies
10/18/2006	EP1711185A1 Combination of a cdk inhibitor and cs-682 or a metabolite thereof
10/18/2006	EP1711177A1 1H-THIENO 2,3-c PYRAZOLE DERIVATIVES USEFUL AS KINASE I INHIBITORS
10/18/2006	EP1711176A1 Immunomodulatory alkaloids
10/18/2006	EP1711174A1 Adjuvant compositions
10/18/2006	EP1414830B1 Tumour inhibiting lanthane compounds
10/18/2006	EP1414829B1 Tumour inhibiting cerium compounds
10/18/2006	EP1389236B1 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof
10/18/2006	EP1358332B1 A serpin in bifidobacteria
10/18/2006	EP1283828B1 Novel polymorph v of torasemide
10/18/2006	EP1189897B1 Isoflavone metabolites
10/18/2006	EP1165778B1 Uses of casb618 polynucleotides and polypeptides
10/18/2006	EP1107957B1 Pyrimidine compounds
10/18/2006	EP1019500B1 Ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons
10/18/2006	EP1007082B1 Modified tumor necrosis factor
10/18/2006	EP1003533B1 Use of herpes vectors for tumor therapy
10/18/2006	EP0991661B1 Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof
10/18/2006	EP0979239B1 Prevention and treatment of hepatocellular cancer
10/18/2006	EP0950096B1 Anti-invasive and anti-angiogenic urokinase fragments and their use
10/18/2006	EP0948511B1 Chemical synthesis of nucleosides analogs and their incorporation into polynucleotides
10/18/2006	EP0944649B1 METHYLATED, SmD HOMOLOGOUS PEPTIDES, REACTIVE WITH THE ANTIBODIES FROM SERA OF LIVING BEINGS AFFECTED WITH SYSTEMIC LUPUS ERYTHEMATOSUS
10/18/2006	EP0778849B1 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
10/18/2006	EP0656788B1 Hla binding peptides and their uses
10/18/2006	CN1849400A Polynucleotides and polypeptides of the erythropoietin gene
10/18/2006	CN1849395A HLA-a24 binding cancer antigen peptide derived from ribin
10/18/2006	CN1849337A Compositions and methods for treating cancer using IGSF9 and LIV-1
10/18/2006	CN1849144A Targeting of tumor vasculature using radiolabelled antibody l19 against fibronectin ED-B
10/18/2006	CN1849138A Human anti-NGF neutralizing antibodies as selective ngf pathway inhibitors
10/18/2006	CN1849137A Special reagent for diagnosing and treating disease based on VEFG,HER-2,PSA protein isomer
10/18/2006	CN1849135A Methods for treating interleukin-6-related diseases
10/18/2006	CN1849124A Use of the quinazoline derivative ZD6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeabi
10/18/2006	CN1849122A Method of treating cancer using fpt inhibitors and at least two antineoplastic agents
10/18/2006	CN1847265A Human chorionic gonadotropic hormone beta strand carboxyl terminal 37 peptide polymer and its use
10/18/2006	CN1847253A Process for preparing amine platinum complexes
10/18/2006	CN1847229A Novel compounds
10/18/2006	CN1846785A Freeze dried composition containing genetic engineering fusion protein
10/18/2006	CN1846784A Amphioxus PE glucoprotein and its production process
10/18/2006	CN1846780A Anticancer analgetic Chinese medicine composition and its prepn process
10/18/2006	CN1846776A Injection of long-chain fat from zedoary oil and its prepn process
10/18/2006	CN1846773A Bladder cancer treating Chinese medicine prepn
10/18/2006	CN1846723A Luhuapan soft capsule and its prepn process
10/18/2006	CN1846712A Cinobufagin emulsion for injection and its prepn process
10/18/2006	CN1846694A Substituted aromatic radical biguanide compounds and the application of their medicine composition in preparing medicine for resisting malignant tumors
10/18/2006	CN1846692A Long circulation liposome prepn of polyene taxol and its prepn process
10/18/2006	CN1846691A Long circulation liposome with modified integrin and carried anticancer medicine for injection
10/18/2006	CN1846689A Slow-released anticancer prepn containing taxane and its synergist
10/18/2006	CN1846688A Slow-released anticancer prepn containing taxane and its synergist
10/18/2006	CN1846687A Slow-released prepn containing taxane and its synergist
10/18/2006	CN1846686A Slow-released injection containing taxol and its synergist
10/18/2006	CN1846685A Slow-released injection containing bendamustine and its synergist
10/18/2006	CN1846684A Slow-released injection containing methotrexate synergist
10/18/2006	CN1846683A Slow-released injection containing methotrexate synergist
10/18/2006	CN1846682A Slow-released anticancer prepn containing methotrexate
10/18/2006	CN1846681A Slow-released injection containing methotrexate and its synergist
10/18/2006	CN1846680A Slow-released methotrexate injection
10/18/2006	CN1846679A Slow-released injection containing methotrexate and its synergist
10/18/2006	CN1846678A Slow-released anticancer injection
10/18/2006	CN1846677A Slow-released injection containing fluoroplex synergist
10/18/2006	CN1846676A Slow-released injection containing fluoroplex synergist and its prepn process
10/18/2006	CN1846675A Slow-released anticancer medicine prepn containing 5-Fu synergist
10/18/2006	CN1846673A Slow-released anticancer medicine prepn containing pyrimidine medicine
10/18/2006	CN1280307C Cytotoxin T lymphocyte
10/18/2006	CN1280288C Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
10/18/2006	CN1280287C Process for producing crystal
10/18/2006	CN1280276C 9-aminoacridine derivatives and process for the preparation thereof
10/18/2006	CN1280267C Sulfonylaminocarboxylic acids
10/18/2006	CN1280250C Benzoquinone compound preparation method and application thereof
10/18/2006	CN1280249C Tricyclopolyketone compound preparation method and application
10/18/2006	CN1279980C Anti solid tumor medicine composition
10/18/2006	CN1279946C Medicinal wine and its producing method
10/18/2006	CN1279934C Composite Chinese medicine for treating malignant solid tumor and its prepn.
10/18/2006	CN1279928C Extracts and use of Leimo
10/18/2006	CN1279922C Paeonal injection emulsion for anti-tumor and its preparing method
10/18/2006	CN1279912C Use of sinomenine
10/18/2006	CN1279907C Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy

1 ... 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 ... 2211